In addition, the mRNA level of PSG9 significantly increased with an increase in the transcription factor AP-2α (TFAP2A) in lung adenocarcinoma, which predicts poorer OS and PFS, probably because of the promotion of tumor metastasis (Xiong et al., 2021). This evidence concerns the gene TFAP2A and lung adenocarcinoma.